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CONCLUSION: In our diarrhoeal patients, CDC is now less common in IBD
than in non-IBD patients. We also found no CDI in our 88 IBD samples.
Although the period studied was short and the numbers of samples limited,
our results suggest that the recent ‘epidemic’ of CDI in IBD patients may now
be on the wane.
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INTRODUCTION: The general psychopathology and coping processes of
Crohn’s disease (CD) patients are incompletely understood. Since these elements
are expected to impact on quality of life, it is necessary to define their relation-
ships precisely. The social constructionist perspective has become a useful frame-
work for understanding coping strategies of men and women. This study
examines emotional distress and coping strategies between the genders.
AIMS & METHODS: 158 consecutive CD patients undergoing clinical assess-
ment at the IBD Clinic completed a series of questionnaires: Brief Symptom
Inventory (BSI) which measures psychological distress (range: 0¼ "not at all"
to 4¼ "extremely distressed"), Ways of Coping (WAYS) that measures thoughts
and actions that people use to handle stressful encounters (range: 1-8, greater
value¼higher use), and IBDQ (disease-specific quality of life). Appropriate uni-
variate analysis was performed. Data given as mean  SD.
RESULTS: 135 patients (85%) completed the questionnaires, 62 men (age 39.1 
14.9 years, Harvey-Bradshaw Index (HBI) 7.1  3.7, disease duration 2.2  0.3
years) and 73 women (age 43.5  17.2, HBI 7.9  4.4, disease duration 2.4  0.8).
BSI scores for somatization (1.15), obsessive-compulsive behavior (1.10), inter-
personal sensitivity (0.83), depression (0.81), anxiety (1.08), hostility (0.79),
phobic anxiety (0.65), paranoid ideation (0.81) and psychoticism (0.59) revealed
low levels of psychological distress and did not differ significantly between men
and women. WAYS scores without gender differences were: range 46: accep-
tance, self-blame, active coping; range 5-6: self-distraction, planning, positive
reframing; range 2-4.9: humor, religion, denial, behavioral disengagement, sub-
stance use. WAYS scores with gender differences were: use of emotional support
(men 4.03, women 4.80, p50.02), use of instrumental support (3.92, 4.64,
p50.03), venting (3.48, 4.32, p50.005). BSI depression correlated with WAYS
instrumental support (p¼ 0.01), behavioral disengagement (p50.03), and self-
blame (p50.02). IBDQ scores were men 49.2  14.9; women 48.6  12.6.
Significant correlations were found between IBDQ and the WAYS scores of
self-distraction, denial, behavioral disengagement, venting, self-blame and reli-
gion; and HBI with the BSI scores of somatization, positive symptom total and
positive symptom distress index. IBDQ correlated with HBI (p50.001).
CONCLUSION: In this recently-diagnosed CD cohort, men and women had
similar levels of disease activity and psychological distress. The most prominent
positive coping mechanisms were acceptance and active coping, and negative
trends of self-blame and self-distraction. Women practiced more emotional sup-
port, instrumental support and venting. These findings need attention in clinical
practice. [Supported by a generous grant from the Leona M. and Harry B.
Helmsley Charitable Trust].
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INTRODUCTION: Little is known about the prevalence and influence of alco-
hol consumption on the disease course in patients with IBD.
Pathophysiologically alcohol might have an impact on disease course by increas-
ing intestinal permeability, disrupting gut barrier function, inhibiting intestinal
immune system and favouring bacterial overgrowth. Otherwise, low to moderate
alcohol consumption might have an anti-inflammatory effect by lowering IL-6
and TNF- levels.
AIMS & METHODS:We aimed to estimate the prevalence of alcohol consump-
tion and its influence on disease course within the Swiss IBD cohort. Frequency
of alcohol consumption was assessed in a screening question provided in the
enrolment questionnaire of the Swiss IBD cohort. According to the given
answers patients were distributed in 3 categories: non-drinkers (abstainers or
rarely), light-to-moderate drinkers (1-2x per week to daily alcohol consumption),
heavy drinkers (4¼ 2x daily). At enrolment socio-demographic variables and
disease characteristics were compared cross-sectionally to identify risk factors for
increased alcohol consumption and to evaluate a possible influence of alcohol
consumption on disease course. During follow-up need for surgeries and occur-
rence of abscesses and fistulas were compared prospectively between the 3
groups.
RESULTS: 2019 patients, who had answered the question about alcohol con-
sumption at enrolment in the Swiss IBD cohort between July 2006 and May
2013, were included in the analysis. 870 patients (43%) drank regularly alcohol:
818 low-to-moderately, 52 heavily. Drinkers were older, by the majority male,
had a higher body mass index and smoked more often. The proportion of
Crohn’s disease patients was lower in non-drinkers (59%) compared to low-to-
moderate drinkers (52%). Drinkers reported less extraintestinal manifestations
than non-drinkers (32% vs. 39%, P50.01). Low-to moderate drinkers (31%)
with ulcerative colitis have a lower (p¼ 0.03) proportion of pancolitis than non-
drinkers (41%). However heavy drinkers with ulcerative colitis had to be hospi-
talized less often before enrolment,which, after stratification, seems to be due to
the known protective effect of smoking. Generally heavy drinkers received sig-
nificantly less immunomodulators (AZA, MTX) and anti-TNF-inhibitors.
During follow-up (6925 patient-years) the need for surgery was similar among
non-drinkers and low-to-moderate drinkers. However heavy drinkers with
Crohn’s disease had to undergo less surgeries and developed fewer abscesses
and fistulas.
CONCLUSION: The prevalence of regular alcohol consumption within the
Swiss IBD cohort was 43%, whereof 94% drank low-to-moderately. Patients
with higher alcohol consumption were older, preferably males with a higher
body mass index and more often smokers. Heavy drinkers received less treatment
with immunosupressants. In ulcerative colitis low-to-moderate drinking seemed
to favour a shorter extent and heavy drinkers were less hospitalized. In Crohn’s
disease heavy drinking seemed to reduce the development of abscesses and fis-
tulas and the need for surgeries during follow-up. A prospective project nested
within the Swiss IBD cohort for a better understanding of alcohol on disease
course is ongoing.
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INTRODUCTION: Limited data are available on the hospitalization rates in
population-based studies. This is a very important outcome measure.
AIMS & METHODS: The aim of this study was to analyze prospectively if early
hospitalization is associated with the later disease course as well as to determine
the prevalence and predictors of hospitalization and re-hospitalization in the
population-based UC inception cohort in the Veszprem province database
between 2000 and 2012. Data of 347 incident UC patients diagnosed between
January 1, 2000 and December 31, 2010 were analyzed (m/f: 200/147, median age
at diagnosis: 36, IQR: 26-50 years, duration: 7, IQR 4-10 years). Both in- and
outpatient records were collected and comprehensively reviewed.
RESULTS: Probabilities of first UC-related hospitalization and first re-hospita-
lization were 28.6%, 53.7%, 66.2% and 23.7%, 55.8% and 74.6% after 1, 5 and
10 years of follow-up in Kaplan-Meier analysis. Main reasons for first hospita-
lization were diagnostic procedures (26.7%), disease activity (22.4%) or UC
related surgery (4.8%), but the majority of the hospitalizations were unrelated
to UC (44.8%). In Kaplan-Meier and Cox-regression analysis disease extent at
diagnosis (HR: 1.35, p¼ 0.018, HRextensive: 1.79, p¼ 0.02 vs. proctitis) or at last
follow-up (HR: 1.56, p¼ 0.001), need for steroids (HR: 1.98, p50.001),
azathioprine (HR: 1.55, p¼ 0.038) and anti-TNF (HR: 2.28, p50.001) were
associated with the risk of UC-related hospitalization. Early hospitalization
was not associated with a specific disease phenotype, however 46.2% of all
colectomies were performed in the year of diagnosis.
CONCLUSION: Hospitalization and re-hospitalization rates are relatively high
in this population-based UC cohort. Early hospitalization was not predictive for
the later disease course.
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INTRODUCTION: Assessment of disease activity in Inflammatory Bowel
Disease (IBD) is challenging as the gold standards of endoscopy and histology
are invasive, expensive and impractical for regular use. Faecal calprotectin (FC)
is increasingly being used as a biomarker of intestinal inflammation but its role in
predicting endoscopic and histological changes in IBD is limited. We explore the
role of FC to assess histological disease in IBD patients, in comparison to C-
reactive protein (CRP), in the largest series of IBD patients to date.
AIMS & METHODS: Retrospective analyses of 407 IBD patients who had a
colonoscopy with FC (mg/g) and CRP (mg/L) measurements. The most severe
histological inflammation found was graded according to the simplified histology
score (0-normal, 1-mild, 2-moderate, 3-severe). Spearman’s correlation coeffi-
cient (r) was used to measure correlation between the groups. Receiver operating
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